New score aims to predict survival in metastatic cancer

NCT ID NCT05100342

Recruiting now Knowledge-focused Sponsor: Indiana University Source: ClinicalTrials.gov ↗

First seen Jan 11, 2026 · Last updated May 23, 2026 · Updated 16 times

Summary

This study tests a simple scoring system to predict if patients with metastatic cancer will survive at least 30 days. Researchers will assign a score based on lab results, emergency room visits, and cancer type. The goal is to help doctors and patients make better decisions about palliative radiation therapy.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for METASTATIC CANCER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Locations

IU Health North / Schwarz Cancer Center
RECRUITING

Carmel, Indiana, 46032, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••
IU Health West
RECRUITING

Avon, Indiana, 46123, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••
Methodist Hospital
RECRUITING

Indianapolis, Indiana, 46202, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

METASTATIC CANCER